Income Statement
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $156K | — | -56.7% |
| Cost of Revenue | $75K | — | -65.7% |
| Gross Profit | $81K | — | -42.8% |
| R&D Expense | $17K | — | -8.3% |
| SG&A Expense | $113K | — | -14.7% |
| Operating Income | -$50K | — | -365.6% |
| Interest Expense | $13K | — | +99.9% |
| Pre-tax Income | -$69K | — | -157.3% |
| Income Tax | $0 | — | — |
| Net Income | -$69K | — | -157.3% |
Balance Sheet
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $7K | +74.4% | — |
| Inventory | $303K | +2.2% | -44.9% |
| Current Assets | $850K | +28.0% | -0.6% |
| Total Assets | $889K | +17.9% | -15.7% |
| Current Liabilities | $1.8M | +12.5% | -16.4% |
| Total Liabilities | $2.0M | +11.1% | -16.5% |
| Stockholders' Equity | -$1.1M | -6.4% | +17.2% |
Cash Flow
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $19K | — | +117.5% |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $46K | — | -8.9% |